The report provides market dynamics and trends related to the clinical trial imaging services market. Furthermore, it includes the study of revenue generated from the sales of various types of clinical trial imaging service such as divided into clinical trial design and consultation services, reading & analytical services, operational imaging services, project and data management services, and others. Moreover, the report presents this revenue under the segment service type, which provides an idea about the various services offered by the players operating in the clinical trial imaging services market.

Breast cancer liquid biopsy is a cancer diagnostics test executed to understand molecular aspects of breast cancer across healthcare and research settings, such as hospitals, physicians, and pathological and research laboratories. It is a non-invasive blood test that provides researchers, physicians, and surgeons with information about cancer profile of a patient and appropriate therapy to improve survival rate of such patients. The report provides market dynamics and trends related to the global breast cancer liquid biopsy market. The study estimates revenue generated from sales of breast cancer liquid biopsy products and services. The valuations comprise revenue generated from reagents, instruments, and services.

Blood purification involves removal of blood from a patient’s body with the help of tubing, extracorporeal cleaning using a device and returning it to the patient’s blood circulation system. For the purpose of analysis, the report segments the global market based on product type, indication, end user, and region. The report provides information about the various types of blood purification devices and consumables used during blood purification treatment. In addition, it provides details about the use of blood purification equipment in various indication such as sepsis, renal diseases, and other diseases such as hepatic failures, drug intoxication, acute pancreatitis, and infectious diseases among others. It further outlines the particulars about the major end users of blood purification equipment, including hospitals and clinics, dialysis centers and other end users such as ambulatory surgical centers, homecare, universities and research institutes. Moreover, it stipulates revenue generated through the sale of blood purification equipment across North America, Europe, Asia-Pacific, and LAMEA.

The global AI in healthcare market is estimated to grow at a CAGR of 49.8% from 2020 - 2027. Key factors that are driving growth of the market are rising application of artificial intelligence (AI) in healthcare, growing investment in ai healthcare startups and increasing cross-industry partnerships and collaborations are anticipated to drive the market. However, the dearth of skilled ai workforce and imprecise regulatory guidelines for medical software is hampering the growth of the market.

The global AI in healthcare market is highly fragmented in nature. The market comprises various emerging and established companies, such as General Electric Company, Medtronic plc, and Allscripts Healthcare Solutions, Inc. Moreover, the global companies hold 40.56% cumulatively in the global AI in healthcare market. The emerging companies vary significantly in their product offerings. The following table represents the emerging companies across various AI-enabled healthcare applications.

On January 8, 2020, the pathogen of severe unexplained viral pneumonia was identified. This was sequenced to be the new coronavirus 2019 (2019-nCoV). On February 12, 2020, the International Committee on Taxonomy of Viruses named it 2019-nCoV, which was officially named SARS-CoV-2. The World Health Organization (WHO) eventually declared the disease caused by SARS-CoV-2 coronavirus disease in 2019 (COVID-19). This virus has affected more than 100 million people and killed millions, causing difficulty breathing.